APA (7th ed.) Citation

Grakova, E. V., Teplyakov, A. T., Kopieva, K. V., Akhmedov, S. D., Ogurkova, O. N., & Soldatenko, M. V. (2018). Prediction role of a novel biomarker ST2 in risk assessment of adverse cardiovascular events in chronic heart failure with preserved and intermediate ejection fraction after myocardial revascularization. «SILICEA-POLIGRAF» LLC.

Chicago Style (17th ed.) Citation

Grakova, E. V., A. T. Teplyakov, K. V. Kopieva, Sh. D. Akhmedov, O. N. Ogurkova, and M. V. Soldatenko. Prediction Role of a Novel Biomarker ST2 in Risk Assessment of Adverse Cardiovascular Events in Chronic Heart Failure with Preserved and Intermediate Ejection Fraction After Myocardial Revascularization. «SILICEA-POLIGRAF» LLC, 2018.

MLA (9th ed.) Citation

Grakova, E. V., et al. Prediction Role of a Novel Biomarker ST2 in Risk Assessment of Adverse Cardiovascular Events in Chronic Heart Failure with Preserved and Intermediate Ejection Fraction After Myocardial Revascularization. «SILICEA-POLIGRAF» LLC, 2018.